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Abstract
Background and Purpose Randomized controlled trials have challenged the assumption that reperfusion success after
mechanical thrombectomy varies depending on the retrieval techniques applied; however, recent analyses have suggested
that acute ischemic stroke (AIS) patients showing susceptibility vessel sign (SVS) may respond differently. We aimed to
compare different stent retriever (SR)-based thrombectomy techniques with respect to interventional outcome parameters
depending on SVS status.
Methods We retrospectively reviewed 497 patients treated with SR-based thrombectomy for anterior circulation AIS.
Imaging was conducted using a 1.5T or 3T magnetic resonance imaging (MRI) scanner. Logistic regression analyses were
performed to test for the interaction of SVS status and first-line retrieval technique. Results are shown as percentages, total
values or adjusted odds ratio (aOR) with 95% confidence intervals (CI).
Results An SVS was present in 87.9% (n= 437) of patients. First-line SR thrombectomy was used to treat 293 patients,
whereas 204 patients were treated with a combined approach (COA) of SR and distal aspiration. An additional balloon-guide
catheter (BGC) was used in 273 SR-treated (93.2%) and 89 COA-treated (43.6%) patients. On logistic regression analysis,
the interaction variable of SVS status and first-line retrieval technique was not associated with first-pass reperfusion (aOR
1.736, 95% CI 0.491–6.136; p= 0.392), overall reperfusion (aOR 3.173, 95% CI 0.752–13.387; p= 0.116), periinterventional
complications, embolization into new territories, or symptomatic intracerebral hemorrhage. The use of BGC did not affect
the results.
Conclusion While previous analyses indicated that first-line SR thrombectomy may promise higher rates of reperfusion
than contact aspiration in AIS patients with SVS, our data show no superiority of any particular SR-based retrieval technique
regardless of SVS status.
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Abbreviations
AIS Acute ischemic stroke
BGC Balloon-guide catheter
COA Combined approach
DSA Digital subtraction angiography
FPR First-pass reperfusion
MCA Middle cerebral artery
MT Mechanical thrombectomy
NIHSS National Institutes of Health Stroke Scale
SR Stent retriever
SVS Susceptibility vessel sign
SWI Susceptibility-weighted imaging
Introduction
Mechanical thrombectomy (MT) is a safe and highly effec-
tive treatment for acute ischemic stroke (AIS) in patients
with large vessel occlusions [1]. Nevertheless, efforts to
increase the chances of reperfusion after MT continue. Re-
cent studies have focused on the identification of critical
clot characteristics visible on imaging that might guide the
choice of the best retrieval technique [2–4]. Due to the para-
magnetic property of deoxygenated hemoglobin in trapped
blood cells, susceptibility-weighted sequences can be used
to locate thrombus material in occluded vessels after AIS,
which may be seen as a distinct loss of signal within the af-
fected vessel. This phenomenon, which is most commonly
referred to as susceptibility vessel sign (SVS), is frequently
observed in AIS patients with admission magnetic reso-
nance imaging (MRI) [4–8]. Previous studies have shown
that SVS is associated with successful reperfusion and fa-
vorable clinical outcome after MT [6]; however, informa-
tion on the role of first-line MT techniques in AIS patients
with or without SVS is scarce. Bourcier et al. [4] indicated
that stent retriever (SR) thrombectomy may be superior to
contact aspiration for treating patients with SVS.
We aimed to compare reperfusion success as well as peri-
interventional and postinterventional complication rates be-
tween patients with anterior AIS treated with first-line SR
and those treated with the combined approach (COA), com-
posed of SR thrombectomywith additional distal aspiration,
depending on SVS status.
Methods
Inclusion Criteria
All data analyzed in this study were gathered retrospec-
tively by reviewing a prospective stroke database that con-
secutively enrolled all AIS patients who underwent MT at
our hospital between January 2010 and December 2018. Pa-
tients fulfilling the following criteria were included: (1) a
final diagnosis of stroke in the anterior circulation, (2) sus-
ceptibility-weighted imaging (SWI) available on baseline
MRI, (3) corresponding occlusion of at least one intracra-
nial artery on digital subtraction angiography (DSA), and
(4) arterial vessel occlusion treated using a SR-based re-
trieval technique. The SWI quality was classified as ex-
cellent (if there were no artifacts), good (in case of minor
artifacts), poor (if there were major artifacts but SVS was
assessable) or very poor (if SVS was not assessable due to
major artifacts). The SVS was considered technically unde-
terminable if the thrombus was masked due to its proximity
to the skull base or it was overlain by other pathologies (i.e.
hemorrhage). Patients with very poor quality SWI or techni-
cally undeterminable SVS status were excluded. All stroke
patients admitted to our institution are primarily scanned
via MRI; however, the final decision on whether to perform
MRI or computed tomography (CT) is made by the neuro-
radiologists and neurologists in charge on a case by case
basis depending on clinical aspects and contraindications.
An SWI was an inherent part of our MRI stroke protocol
throughout the duration of this study. It was only omitted
when it was likely that it would yield inconclusive results
based on the sequences performed beforehand (i.e. artifacts
due to presence of foreign objects or motion artifacts). Eth-
ical approval was obtained prior to conducting this study.
Patients included on 1 January 2015, or later gave writ-
ten or oral consent regarding use of their data for research.
The need for consent was waived according to national law
and regulations of the local ethics committee for patients
included before this date.
Analysis of Clinical Information
Information on the following demographics, baseline char-
acteristics, clinical data, and cardiovascular risk factors was
collected: age, sex, history of stroke, medication before AIS
(antiplatelet therapy, anticoagulants, statins), hypertension,
diabetes mellitus, dyslipidemia, and smoking habits. In ad-
dition, we recorded blood pressure (systolic and diastolic),
glucose levels and the National Institutes of Health Stroke
Scale (NIHSS) on admission, and stroke subtypes according
to trial of Org 10,172 in acute stroke treatment (TOAST)
classification. Also, intravenous thrombolysis prior to imag-
ing (transfer patients) and prior to MT, time from symptom
onset/last seen well to admission, time from symptom on-
set/last seen well to MT, and time from groin puncture to
reperfusion were documented.
Technical Information onMRI
The SWI was acquired on a 1.5T or 3T MRI scanner
(1.5T: MAGNETOM Avanto or MAGNETOM Aera; 3T:
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Fig. 1 A patient with acute ischemic stroke and complete occlusion of the left middle cerebral artery (MCA) main trunk (M1 segment). SVS
visible on SWI (a) as signal loss along the main trunk of the MCA representing the occlusive thrombus. Vessel occlusion is also seen on arterial
time-of-flight sequence (aTOF; b) and on digital subtraction angiography (c). Yellow crosshairs are centered on the proximal end of the vessel
occlusion on SWI (a) and on aTOF (b). The blue arrow points to the proximal end of the vessel occlusion on digital subtraction angiography (c)
Fig. 2 A patient with acute is-
chemic stroke. Susceptibility-
weighted imaging (SWI) shows
no SVS (a). Complete proximal
occlusion of the left middle cere-
bral artery (MCA) main trunk
(M1-segment) is seen on arterial
time-of-flight sequence (aTOF;
b) and on digital subtraction an-
giography (c). Yellow crosshairs
are centered on the proximal
end of the vessel occlusion on
SWI (a) and aTOF (b). The blue
arrow points to the proximal end
of the vessel occlusion on digital
subtraction angiography (c)
MAGNETOM Verio; Siemens Healthcare AG [Erlangen,
Germany]). Repetition time, echo time, flip angle, slice
thickness, and intersection gap for each scanner are listed
in the supplement (Supplementary Table 1).
Imaging Analysis
Two independent neuroradiologists (N.F.B. and E.A.B.),
with 5 and 4 years of experience, assessed SVS retrospec-
tively. They were blinded to all outcome parameters and had
no role in patient treatment. An SWI showing a distinct sig-
nal loss corresponding to an acutely occluded, symptomatic,
intracranial artery was classified as SVS˚ regardless of its
diameter compared to that of the contralateral artery (Fig. 1)
if there were no alternative explanations for the signal loss
observed (i.e. neighboring vein, petechial hemorrhage or
microcalcification in the neighboring parenchyma). An SWI
showing no SVS was classified as SVS (Fig. 2). DWI-
ASPECTS (diffusion-weighted imaging Alberta stroke pro-
gram early CT score) was evaluated on diffusion-weighted
imaging. In addition, MRI field strength and time from
symptom onset to imaging was documented for each pa-
tient.
Digital Subtraction Angiography and Mechanical
Thrombectomy
Conventional angiography was used to determine the pri-
mary site of intracranial occlusion as well as the presence of
additional occlusions upstream. Experienced interventional
neuroradiologists performed all MTs according to the cur-
rent clinical practice guidelines and institutional protocols.
First-line retrieval technique was documented as follows:
stent retriever only (SR) or COA [= SR plus distal aspira-
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Table 1 List of stent retriever devices used in this study
Device name Size (mm)a Number of patients treated
Solitaire FR (Medtronic, Irvine, California, USA)b 4× 20/6× 30/4× 40 425
Catch (Balt, Montmorency, France)b 3× 15/4× 20/5× 35 35
Mindframe (Medtronic, Irvine, California, USA)c 3× 15 21
Trevo Provue (Stryker, Kalamazoo, Michigan, USA)c 4× 30/6× 25 10
Embotrap (Nauravi, Galway, Ireland)c 5× 21 5
Preset LT (Phenox, Bochum, Germany)b 4× 20 1
aFor each device, the first value is the nominal diameter and the second value is the usable stent length expressed in mm
bIncomplete axial section device
cComplete axial section device
tion]. Table 1 lists all the first-line stent retriever devices
used to treat the patients in this study. All distal aspiration
catheters are listed in Supplementary Table 2. The addi-
tional use of a BGC was documented separately. The ex-
panded thrombolysis in cerebral infarction (eTICI) score
[9] was documented after the first pass and at the end of
the procedure. Also, the total number of passes performed
during MT was recorded. Reperfusion was considered suc-
cessful if eTICI was 2B or better. A research fellow with
3 years of experience (J. K.) screened all angiography im-
ages for embolization into previously unaffected (= new)
territories (ENT) and periinterventional complications (va-
sospasm, dissection and/or perforation).
Outcome
The NIHSS was evaluated a second time at 24h after MT
by a neurologist, whereas the modified Rankin scale (mRS)
and mortality were assessed at 90 days after treatment by
a neurologist or a certified study nurse. We defined early
neurological recovery as a ≥4-point decrease of NIHSS 24h
after treatment compared to admission. Patients with mRS
≤2at 90 days after treatment were considered functionally
independent. Symptomatic intracerebral hemorrhage within
48h after MT was assessed according to the European Co-
operative Acute Stroke Study (ECASS II) definition [10].
Statistical Analysis
SPSS software (Version 25.0; IBM, Armonk, NY, USA)
was used to perform statistical analyses. Continuous vari-
ables were compared with the Mann-Whitney U-test and
categorical variables with the χ2-test. The association of
first-pass reperfusion (FPR), overall reperfusion, thrombec-
tomy-related complications (i.e., peri-interventional com-
plications, ENT, and symptomatic intracerebral hemor-
rhage), and early neurological recovery with SVS and first-
line retrieval technique was examined using multivariable
binary logistic regression models. Adjustment was done for
all cofactors with p< 0.15 as well as additional cofactors
that are known or suspected to influence those parameters
(additional base cofactor for all outcome variables: age, sex,
bridging therapy, previous stroke, stroke subtype; additional
base cofactor for thrombectomy-related complication pa-
rameters: successful reperfusion; additional base cofactor
for early neurological recovery: pre-stroke mRS >2, DWI-
ASPECTS, successful reperfusion, time to reperfusion,
and symptomatic intracerebral hemorrhage). Results with
two-tailed p-values of <0.05 were considered statistically
significant and are shown as total values (n), percentages
with respective p-values, medians with respective p-values,
or adjusted odds ratio (aOR) with respective 95% CIs.
Results
Our study identified 1317 AIS patients who underwent
MT between January 2010 and December 2018. Admis-
sion MRI was available for 676 patients and SWI for 614 of
them. A total of 37 patients were excluded due to very poor
quality SWI or technically undeterminable SVS status. Pa-
tients with posterior circulation stroke (n= 44) and patients
treated with contact aspiration only (n= 36) were also ex-
cluded. Overall, 293 were treated with SR only, whereas
204 were treated with COA. A BGC was used in 273
patients treated with SR only (93.2%) and in 89 patients
treated with COA (43.6%). Acute ischemic stroke patients
with admission CT instead of admission MRI had signif-
icantly higher admission NHISS, higher NIHSS at 24h,
lower reperfusion rates, lower rates of functional indepen-
dence at 90 days, and higher mortality rates at 90 days
(Supplementary Table 3); however, patients for whom SVS
was assessable did not differ significantly from patients with
nonassessable SVS with respect to demographics and core
outcome parameters (Supplementary Table 4). Patients ex-
cluded due to posterior circulation stroke were significantly
younger and had lower admission NIHSS than patients who
were included but did not differ with respect to reperfu-
sion and clinical outcome (Supplementary Table 5). Inter-
rater reliability for SVS classification was strong (κ= 0.876,
p< 0.001). All baseline characteristics and stroke-related
data as well as all interventional and clinical outcome re-
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Table 2 Baseline characteristics and clinical data upon admission for the stent retriever (SR) and combined approach (COA) group







Age 497/497 (100%) 74.7 (62.6–82.0) 74.5 (62.5–82.3) 75.0 (62.5–81.5) 0.943
Sex, female 497/497 (100%) 51.7% (257) 52.6% (154) 50.5 (103) 0.650
Risk factors
Hypertension 497/497 (100%) 66.6% (331) 66.2% (194) 32.8% (67) 0.826
Smoking 497/497 (99.8%) 26.4% (131) 28.3% (83) 23.5% (48) 0.224
Diabetes mellitus 497/497 (100%) 14.1% (70) 15.4% (45) 12.3% (25) 0.328
Coronary heart disease 493/497 (99.2%) 15.3% (76) 15.4% (45) 15.2% (31) 0.972
Dyslipidemia 495/497 (99.6%) 58.4% (290) 58.7% (172) 57.8% (118) 0.863
Previous stroke 497/497 (100%) 11.3% (56) 11.6% (34) 10.8% (22) 0.776
Pre-stroke mRS >2 496/497 (99.8%) 8.2% (41) 7.8% (23) 8.8% (18) 0.706
Antiplatelet therapy 495/497 (99.6%) – – – 0.536
None – 67.4% (335) 69.3% (203) 64.7% (132) –
Mono – 30.2% (150) 28.7% (84) 32.4% (66) –
Dual – 2.0% (10) 1.7% (5) 2.5% (5) –
Anti-coagulation 494/497 (99.4%) – – – 0.952
None – 87.1% (433) 86.7% (254) 87.7% (179) –
Vitamin K antagonist – 6.2% (31) 6.5% (19) 5.9% (12) –
NOAC – 6.0% (30) 6.1% (18) 5.9% (12) –
Other medication 495/497 (99.6%) – – – –
Statin – 25.4% (126) 26.6% (78) 23.5% (48) 0.441
Other clinical data
Systolic BP, mmHg 487/497 (98.0%) 155.0 (135.0–173.0) 152.0 (134.0–171.8) 158.0 (137.0–175.0) 0.121
Diastolic BP, mmHg 488/497 (98.2%) 81.0 (71.0–95.0) 80 (70.5–95.0) 83.0 (72.0–94.0) 0.800
Admission glucose,
mmol/L
488/497 (98.2%) 6.5 (5.8–7.5) 6.5 (5.7–7.7) 6.4 (5.8–7.1) 0.088
Admission NIHSS 497/497 (100%) 12 (7–18) 13 (8–18) 11 (6–17) 0.002a
Data are expressed as percentage (n) or median (interquartile range 25–75%)
BP blood pressure, DWI-ASPECTS diffusion-weighted imaging Alberta stroke program early CT score, NIHSS National Institutes of Health
Stroke Score, NOAC new oral anticoagulants, mRS modified Rankin scale, BP blood pressure
aStatistically significant
sults for the SR and COA groups are provided in Tables 2,
3 and 4.
The glucose level on admission tended to be higher in
patients treated with SR only than in patients treated with
COA (6.5mmol/L versus 6.4mmol/L, p= 0.088). Admis-
sion NIHSS was also higher in patients treated with SR only
than in those treated with COA (13 versus 11, p= 0.002).
COA was applied more frequently in patients with tandem
occlusions (27.0% versus 8.2%, p< 0.0001). First-line re-
trieval technique differed depending on the primary site of
occlusion (p< 0.0001): SR was more often applied in pa-
tients with M1 occlusions (68.9% versus 46.6%, p< 0.0001)
and COA was preferred for treatment of M2 occlusions
(38.2% versus 13.7%, p< 0.0001).
Association Between First-line Retrieval Technique
and Reperfusion
There was no significant difference in FPR and overall
reperfusion success between patients treated with SR only
versus COA (FPR: 54.6% versus 56.4%, p= 0.765; overall
reperfusion success: 82.3% versus 83.8%, p= 0.647). Time
to reperfusion was shorter in patients treated with SR only
than in patients treated with COA (36min versus 47min;
p< 0.0001).
A multivariable binary logistic regression model that in-
cluded all patients found no association between first-line
SR-based retrieval technique and FPR (aOR 1.172, 95% CI
0.747–1.839; p= 0.490) or overall reperfusion (aOR 1.514,
95% CI 0.841–2.726; p= 0.167).
In another multivariable binary logistic regression
model exclusively considering patients with SVS, first-
line COA was not associated with FPR (aOR, 1.344, 95%
K
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TOAST 495/497 (99.6%) – – – 0.564
Large-artery atherosclerosis – 10.7% (53) 10.6% (31) 10.8% (22) –
Cardioembolic – 46.9% (233) 47.1% (138) 46.6% (95) –
Other determined causes – 5.0% (25) 6.1% (18) 3.4% (7) –
Undetermined – 37.0% (184) 35.8% (105) 38.7% (79) –
Field strength 497/497 (100%) – – 10.8% (22) 0.788
1.5T – 65.4% (325) 65.9% (193) 46.6% (95) –
3T – 34.6% (172) 34.1 (100) 3.4% (7) –
Time to imaging/treatment
Time SO/LSW to admission (min) 486/497 (97.8%) 122.5 (71.0–286.0) 114.0 (69.0–268.0) 133.0 (73.0–310.0) 0.104
IV lysis prior to MRI 497/497 (100%) 6.4% (32) 5.8% (17) 7.4% (15) 0.488
IV lysis prior to MT 497/497 (100%) 38.8% (193) 37.9% (111) 40.2% (82) 0.603
Time SO/LSW to groin puncture
(min)
490/497 (98.6%) 231.0 (164.8–386.5) 229.0 (164.0–372.3) 240.0 (165.8–452.0) 0.317
Time to reperfusion (min) 471/497 (94.8%) 41.0 (28.0–63.0) 36.0 (25.0–60.0) 47.0 (31.8–71.3) 0.000a
Primary site of occlusion 497/497 (100%) – – – 0.000a
Intracranial ICA – 13.9% (69) 16.0% (47) 10.8% (22) –
MCA (M1) – 59.8% (297) 68.9% (202) 46.6% (95) –
MCA (M2) – 23.7% (118) 13.7% (40) 38.2% (78) –
MCA (M3) – 0.6% (3) 0.0% (0) 1.5% (3) –
MCA and ACA involved – 1.0% (5) 1.0% (3) 1.0% (2) –
ACA – 1.0% (5) 0.3% (1) 2.0% (4) –
Tandem occlusion – 84.1% (418) 8.2% (24) 27.0% (55) 0.000a
Imaging
DWI-ASPECTS 493/497 (99.2%) 8 (6–9) 8 (5–9) 8 (7–9) 0.020
SVS 497/497 (100%) 87.9% (437) 88.1% (258) 87.7% (179) 0.917
Data are expressed as percentage (n) or median (interquartile range 25–75%)
ACA anterior cerebral artery, DWI-ASPECTS diffusion-weighted imaging Alberta stroke program early CT score, ICA internal carotid artery,
IV intravenous, LSW last seen well, MCA middle cerebral artery, SO symptom onset, SVS susceptibility vessel sign, T Tesla, TOAST trial of Org
10,172 in acute stroke treatment,
aStatistically significant
CI 0.825–2.190, p= 0.235), but was associated with overall
reperfusion (aOR 2.126, 95% CI 1.079–4.189; p= 0.029).
Applying the same model to patients without SVS
showed that first-line SR was significantly associated with
FPR (aOR 11.268, 95% CI 1.165–109.038; p= 0.036)
and overall reperfusion success (aOR 469.212, 95% CI
2.327–94,618.855; p= 0.023); however, there was no in-
teraction between SVS and retrieval technique in terms of
FPR (aOR 1.736, 95% CI, 0.491–6.136; p= 0.392) or over-
all reperfusion success (aOR 3.173, 95% CI 0.752–13.387;
p= 0.116).
Figures. 3 and 4 show the distribution of first-pass eTICI
according to SR-based retrieval technique in patients with
and without SVS. Exclusion of patients in whom a BGC
was not used did not change the results regarding FPR and
overall reperfusion (Supplementary Tables 7 and 8). Limit-
ing the analyses to cases in which the same brand of stent
retriever was used also did not affect results.
Association Between First-line Retrieval Technique
and Complications
First-line retrieval technique did not significantly affect
the risk of periinterventional complications (14.3% ver-
sus 14.7%; p= 0.920), emboli in previously unaffected
territories (3.8% versus 3.9%; p= 0.930), or symptomatic
intracerebral hemorrhage (3.8% versus 4.9%; p= 0.568).
A multivariable binary logistic regression model that
included all patients found no interaction between SVS and
retrieval technique with respect to periinterventional com-
plications (aOR 0.440, 95% CI 0.079–2.465; p= 0.350),
emboli in previously unaffected territories (did not con-
verge), or symptomatic intracerebral hemorrhage (aOR
0.406, 95% CI 0.024–6.748; p= 0.530).
These observations were unchanged when patients in
whom no BGC was used were excluded (Supplementary
K
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Fig. 3 First-pass expanded treatment in cerebral infarction (eTICI) distribution according to SR-based retrieval technique for patients with acute
anterior circulation stroke with susceptibility vessel sign
Tables 7 and 9) or when analysis was limited to cases in
which the same brand of stent retriever had been utilized.
Clinical Outcome
Early neurological recovery was better for patients treated
with SR than with COA (51.5% versus 34.8%, p= 0.001).
On binary logistic regression analysis, SR was associated
with early neurological recovery (aOR 1.936, 95% CI
1.064–3.523; p= 0.031); however, SVS and retrieval tech-
nique showed no significant interaction with respect to early
neurological recovery (aOR 2.547, 95% CI 0.463–14.000;
p= 0.282).
No differences were seen between groups (SR versus
COA) in terms of overall mRS (1 versus 1; p= 0.596),
functional independence (mRS ≤2; 54.0% versus 50.0%;
p= 0.322), or mortality (19.1% versus 18.1%; p= 0.825)
90 days after treatment. These observations were unchanged
when patients in whom no BGC was used were excluded
(Supplementary Table 3).
Discussion
The main findings of this study were as follows: there were
no significant interactions between SR-based retrieval tech-
nique and SVS status in terms of first-pass reperfusion (1)
and overall reperfusion (2). Regardless of SVS status, there
were no significant differences between treatment with SR
only and COA concerning the risk of periinterventional
complications (3), embolization into new territories (4), or
symptomatic intracerebral hemorrhage (5). Exclusion of pa-
tients in whom a BGC was not used did not change these
observations.
Darcourt et al. [6] have suggested that SVS is associ-
ated with reperfusion after MT. Yet, 19–45% of AIS pa-
tients with SVS show no reperfusion after MT [5–8]. Re-
cent randomized controlled studies have found no associ-
ation between reperfusion success and second-generation
thrombectomy techniques [11, 12]. This raises the question
of whether an individualized strategy for MT techniques
would prove more beneficial. Efforts to increase MT suc-
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Fig. 4 First-pass expanded treatment in cerebral infarction (eTICI) distribution according to first-line SR-based retrieval technique for patients
with acute anterior circulation stroke without susceptibility vessel sign
cess by identifying imaging parameters that would allow
prospective selection of the most effective retrieval tech-
nique for a specific clot are ongoing [2–4]. Bourcier et al.
[4] published the first study comparing MT techniques in
AIS patients with SVS and concluded that first-line SR-
only thrombectomy is superior to contact aspiration among
those patients [4]. Future studies will be needed to test
this hypothesis prospectively (VECTOR trial; ClinicalTri-
als.gov Identifier: NCT04139486). Previous studies have
shown that erythrocyte-rich thrombi are more likely to be
apparent on SWI [13, 14] and are easier to retrieve than
fibrin-rich clots [15]. Retrieving fibrin-rich clots might be
more difficult because of increased vessel wall-clot interac-
tion [16, 17]; however, this interaction, which is primarily
determined by clot histology, should be similar among clots
with the same SVS status. We hypothesize that differences
in device-clot interaction may explain the superiority of SR-
based retrieval techniques in SVS˚ clots.
To the best of our knowledge, this is the first study to
examine different SR-based retrieval techniques in AIS pa-
tients classified according to SVS status. Regardless of SVS
status, our data show no superiority of any particular SR-
based retrieval technique. Various factors may explain this
finding. Even though a combined approach may promise
synergetic effects in some cases, in others we hypothe-
sized that the additional aspiration could also reduce the
device-clot interaction by impairing or reducing the inte-
gration of the thrombus into the stent meshes. The fact that
SR was performed more frequently than COA (SR±BGC:
293 versus COA±BGC: 204) may also play to the effect
that SR was equally successful in the anterior circulation.
Any experience bias in favor of SR thrombectomy could af-
fect reperfusion success and consequently alter results [18].
Future studies could examine the efficacy of different re-
trieval techniques for retrieving clots with varying histolog-
ical composition.
First-line SR-only treatment was associated with early
neurological recovery. Several factors may have contributed
to this finding, some of which were adjusted for in the re-
gression analysis. Admission NIHSS was lower in the COA
K
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Number of passes 497/497 (100%) – – – 0.174
≤3 – 90.3% (449) 90.8% (266) 89.7% (183) –
4–5 – 8.7% (43) 8.5% (25) 8.8% (28) –
≥6 – 1.0 (5) 0.7% (2) 1.5% (3) –
Reperfusion/outcome
Final eTICI ≥2b 497/497 (100%) 82.9% (412) 82.3% (241) 83.8% (171) 0.647
First-pass eTICI ≥2b 466/497 (93.8%) 55.3% (275) 54.6% (160) 56.4% (115) 0.765
NIHSS 24h 437/497 (87.9%) 5 (2–12) 5 (2–12) 6 (2–12) 0.837
NIHSS imp. 24h (total) 437/497 (87.9%) –4 (–9 to 0) –5 (–10 to –1) –2 (–7 to 0) 0.001a
NIHSS imp. 24h ≥4 points 437/479 (87.9%) 44.7% (222) 51.5% (151) 34.8% (71) 0.001a
mRS after 90 days 478/497 (98.0%) 2 (1–4) 1 (1–2) 1 (1–2) 0.596
Post-stroke mRS ≤2 478/497 (98.0%) 52.9% (263) 54.9% (161) 50.0% (102) 0.322
Mortality within 90 days 478/497 (98.0%) 18.7% (93) 19.1% (56) 18.1% (37) 0.825
Complications
Peri-interventional complications 496/497 (99.8) 14.5% (72) 14.3% (42) 14.7% (30) 0.920
Embolization into new territory 496/497 (99.8) 3.8% (19) 3.8% (11) 3.9% (8) 0.930
Symptomatic intracerebral hemorrhage 495/497 (99.6%) 4.2% (21) 3.8% (11) 4.9% (10) 0.529
Data are expressed as percentage (n) or median (interquartile range 25–75%)
eTICI expanded thrombolysis in cerebral infarction, mRS modified Rankin scale, NIHSS National Institutes of Health Stroke Score
aStatistically significant
group, which might have prevented a 4-point NIHSS re-
duction more frequently than in patients treated with SR
only. Tandem occlusions were more frequent in the COA
than in the SR group. Furthermore, the speed of neurolog-
ical recovery might differ depending on the primary site
of occlusion. Time to reperfusion was longer for the COA
group, which is probably due to a combination of factors
(i.e. COA was applied more frequently in tandem and M2
occlusions, it requires positioning of two retrieval devices
rather than one, and it may have been applied more fre-
quently in cases with complex intracranial and extracra-
nial vessel anatomy). The abovementioned experience bias
in favor of SR only could also play a role here. Further-
more, microemboli/microstructural changes are not always
reflected by angiographic grading scales like eTICI [19, 20];
however, our data suggest no significant interaction of SVS
status and first-line SR-based retrieval technique mediating
early neurological recovery.
Regardless of SVS status, the two SR-based retrieval
techniques did not differ in terms of periinterventional or
postinterventional complication rates; however, this does
not mean that additional distal aspiration or proximal flow
protection using a BGC should be avoided. Earlier studies
have found that BGCs may both improve the chances of
reperfusion [21, 22] and decrease the risk of ENT [23].
Despite our results, imaging biomarkers like SVS may
still help to identify patients who are at high risk for futile
reperfusion, or peri-interventional and postinterventional
complications depending on the retrieval approach chosen.
Although the binary classification of SVS does not seem to
offer enough information to guide the selection of a partic-
ular stent-based retrieval technique, modern techniques like
quantitative susceptibility mapping could prove beneficial
by providing more specific information on clot composition
[24, 25].
Limitations
Generalizability might be limited because this was a ret-
rospective, single center study. As suggested in a previ-
ous study and confirmed in the current analysis, baseline
criteria and reperfusion outcome for stroke patients differ
depending on initial imaging modality, which causes se-
lection bias. Since SVS was first described as the gradient
echo susceptibility vessel sign (GRE SVS) in T2*-weighted
gradient echo imaging, most of the studies so far have not
performed SWI, which provides better spatial resolution
and is therefore superior in visualizing smaller clots. The
better differentiation provided by SWI sequences led to an
updated definition of SVS, which is independent of the con-
tralateral vessel diameter. Both of these developments limit
comparability to earlier studies [26]. Several other factors
that may influence reperfusion success, such as clot den-
sity [27, 28], intracranial and extracranial vessel anatomy
[29], and collateral circulation [30] could not be evaluated
owing to the lack of relevant data. The choice of first-line
retrieval technique was at the discretion of the treating neu-
rointerventionalist, which is a source of selection bias. The
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data presented in this study were acquired over a period of
9 years during which interventional treatment standards and
techniques have advanced, which may have influenced re-
sults. Angiography was not always performed after the first
pass, which led to data gaps regarding first-pass eTICI and
may constitute another source of selection bias. Although
the stent-based retrieval techniques examined in this study
(SR only±BCG, COA±BCG) are the only ones used at
our institution and are certainly among the most frequently
used worldwide, there may be other stent-based techniques
that were not considered for this analysis.
Conclusion
While previous analyses have indicated that in AIS patients
with SVS, first-line SR thrombectomy may promise higher
rates of reperfusion than contact aspiration, our data show
no superiority of any particular SR-based retrieval tech-
nique regardless of SVS status; however, a binary classi-
fication of SVS may not provide enough information to
effectively guide choice of retrieval approach. Future stud-
ies will be needed to determine whether modern techniques
like quantitative susceptibility mapping allow a more nu-
anced selection of retrieval technique by providing more
specific information on clot composition.
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